This research paper, published in the International Journal of Drug Policy, examines how interferon-free treatments for hepatitis C are being understood and experienced by patients.
Resources
Medical professional
Around 216,000 people in the UK are living with hepatitis C so it is important that all medical professionals have access to the latest training, information and advice on hepatitis C management. Find here links to relevant materials for clinicians, nurses, GPs, prison healthcare staff and other medical professionals.
Showing 31 to 40 of 231 resources
-
The lived experience of interferon-free treatments for hepatitis C: A thematic analysis
UK Reports & Research PDF -
BBV Bulletin: Quarterly update report of the introduction of opt-out BBV testing in prisons from PHE, NHS England and NOMS
This bulletin provides an update on the introduction of opt-out BBV testing in prisons across England. It provides an overview of results and findings from the 'phase 2 pathfinder' prisons, as well as a range of recommendations including for prison healthcare teams to work more closely with local ODNs to improve uptake and completion of hepatitis C treatment.England Nov 2016 Reports & Research PDF -
Good practice case study: ROADS @ Bristol Drugs Project
This HCV Action good practice case study looks at the work done by ROADS (Recovery Orientated Alcohol & Drugs Service) @ Bristol Drugs Project. When ROADS took over the service in November 2013, under 12% of clients assessed as appropriate to be tested for hepatitis C went on to actually be tested. Bristol ROADS made a concerted effort to increase the number of people receiving hepatitis C tests by better coordinating services and finding ways to address the complications that prevented people who had agreed to be tested for hepatitis C from actually receiving the test.UK, South West Case study PDF -
Global report on access to hepatitis C treatment - Focus on overcoming barriers
This is the first-ever global report on treatment access to hepatitis C medicines. The report provides the information that countries and health authorities need to identify the appropriate HCV treatment, and procure it at affordable prices. The report uses the experience of several pioneering countries to demonstrate how barriers to treatment access can be overcome.Rest of World Oct 2016 Reports & Research PDF -
Laboratory reports of hepatitis C: April to June 2016
This report from Public Health England provides statistics on the number of hepatitis A and hepatitis C laboratory reports in England and Wales from April to June 2016.England, Wales Reports & Research PDF -
Good practice case study: Community pharmacy testing on the Isle of Wight
This HCV Action good practice case study looks at a community pharmacy testing pilot on the Isle of Wight. It involved the delivery of blood borne virus testing at 22 community pharmacies from September 2014 - May 2015. Primarily focused on increasing the numbers of people tested and diagnosed for hepatitis C, it trebled the number of tests carried out in community open access settings, and led to a significant increase in the numbers of people being referred to specialist care.
This case study looks at why the pilot was established, how it operated, and the outcomes that it achieved.UK, South West Oct 2016 Case study PDF -
EASL Recommendations on Treatment of Hepatitis C 2016
These EASL Recommendations on Treatment of Hepatitis C are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the current optimal management of patients with acute and chronic HCV infections. These recommendations apply to therapies that have been approved by the European Medicines Agency and other national European agencies at the time of their publication.Rest of World Sep 2016 Other, Reports & Research PDF -
Working Together to Reduce Harm (Substance Misuse) Delivery Plan 2016 - 2018
This Welsh Government delivery plan describes the work that will be undertaken reduce the harm caused by substance misuse. It includes actions related to hepatitis C such as the implementation of routine opt-out testing in substance misuse services.UK, Wales Sep 2016 Strategy & Planning PDF -
Hepatitis C Coalition: Report on Operational Delivery Network Visits
This report, published by the Hepatitis C Coalition, provides an overview of visits undertaken by the Coalition to Operational Delivery Networks (ODNs) across England. It sets out the detailed analysis of findings from meetings with a variety of health professionals across the country, and includes a number of recommendations intended to further improve the effectivesness of the ODNs.England Sep 2016 Reports & Research PDF -
Together for Health: Liver Disease Annual Report 2016 - Setting the Baseline
This report, published by the Welsh Government and NHS Wales, provides an overview of liver disease in Wales, and gives details of the actions currently underway to tackle liver disease, including hepatitis C.UK, Wales Reports & Research PDF